Nuwellis Inc vs Toyota Motor Corp — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while Toyota Motor Corp trades at $193.77 (market cap $228.43B). The key difference: Toyota Motor Corp is far larger — about 91372× Nuwellis Inc's market cap, and Toyota Motor Corp pays a 3.27% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | TM | |
|---|---|---|
Market Cap | $2.50M | $228.43B |
Sector | Technology | Consumer Cyclical |
52-Week High | $164.50 | $248.29 |
52-Week Low | $0.73 | $166.50 |
Enterprise Value | -$1.21M | $427.29B |
Dividend Yield | — | 3.27% |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
Toyota Motor (TM) trades at $191.45, down 2.87% amid bearish technical signals, though fundamentals remain strong with attractive valuation metrics including a P/E of 8.51 and P/S of 0.74. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $7.57 exceeding estimates by 62%. Recent news highlights strong demand for hybrid models like the RAV4 and strategic partnerships, though tariff threats and a global recall present headwinds.
TM offers value with solid profitability and growth, but faces near-term technical pressure and geopolitical risks. The stock's undervaluation relative to DCF estimates around $342 presents opportunity, yet investors must weigh competitive pressures and macroeconomic uncertainties against the company's operational strength and market leadership in hybrid technology.
Trailing returns across standard periods
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →